Skip to main content

Table 1 Characteristic of patients

From: Linkage of alterations in systemic iron homeostasis to patients’ outcome in sepsis: a prospective study

  All patients (n = 61) Survivor (n = 41) Non-survivor (n = 20) p value
Male, n 37 (60.7%) 22 (53.7%) 15 (75%) 0.163
Female, n 24 (39.3%) 19 (46.3%) 5 (25%) 0.163
Age, years 63 (21–88) 63 (21–88) 67 (53-85) 0.293
SOFA 11 (± 4) 10 (± 3.8) 14 (± 3.2) 0.0002
SAPS II 54 (± 19) 47 (± 16.6) 68 (± 16.9) 0.002
ICU-mortality, n 19 (31.2%)    
Hospital mortality, n 15 (23.4%)    
Pneumonia, n 23 (37.7%) 15 (36.6%) 8 (40%) 0.990
Urinary tract infection, n 6 (12.8%) 5 (12.2%) 1 (5%) 0.654
Acute abdominal infection, n 6 (9.8%) 3 (7.3%) 3 (15%) 0.384
Skin or soft tissue infection, n 6 (9.8%) 4 (9.8%) 2 (10%) 0.990
Blood catheter infection, n 2 (4.3%) 2 (4.8%) 0 0.990
Implant infection, n 1 (2.1%) 1 (2.4%) 0 0.990
Others, n 6 (9.8%) 3 (7.3%) 3 (15%) 0.384
Multiple foci, n 11 (18.0%) 6 (14.6%) 5 (25%) 0.479
patients with malignant diseases, n 11 (18.0%) 6 (14.6%) 5 (25%) 0.479
Septic shock, n 47 (77.1%) 28 (68.3%) 19 (95%) 0.024
Immunosuppresive co-medication, n 26 (41.0%) 15 (36.6%) 11 (55%) 0.270
Red blood cell transfusion (within 3 months before admission, n) 18 (29.5%) 7 (17.0%) 11 (55%) 0.006
  1. Indicated are numbers of patients and in brackets the respective percentage to the cohort (all patients, survivor, non-survivor)
  2. Age is reported as median and range, SOFA and SAPS II scores are reported as mean ± SD
  3. p values were determined by Fisher’s exact test, t test, Mann-Whitney test